IDEFIRIX 11 mg, powder for concentrate for infusion 2 bottles
Active ingredients: IMLIFIDASE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusion2 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IDEFIRIX 11 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre
- Marketing authorisation holder
- SERB (BELGIQUE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Apr 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66170619CIP75508236CIP133400955082361Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMLIFIDASEpoudre | 11 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.